Speaker illustration

Doctor Mohammad Abdelghani

Al-Azhar University, Cairo (Egypt)

Member of:

European Society of Cardiology

Dr. Abdelghani is an Interventional Cardiologist and a Lecturer of Cardiology at Al-Azhar University, Cairo, Egypt and a scientific researcher at the Academic Medical Center, University of Amsterdam, The Netherlands. Dr. Abdelghani has authored over 60 peer-reviewed articles and many book chapters, is an editorial board member and has served as an associate editor for EuroIntervention journal, and served as invited faculty in many congresses including EuroPCR and CSI. His main focus of scientific interest is Valvular Heart Disease and Transcatheter Interventions for Adulthood Structural Heart Diseases.

Impact of prosthetic valve regurgitation quantified by cardiac magnetic resonance imaging on long-term mortality after TAVI

Event: ESC Congress 2018

Topic: Aortic Valve Intervention

Session: Controversies and unmet needs around TAVI


Aortic root changes after device closure of interatrial communications

Event: ESC Congress 2018

Topic: Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure

Session: Non-coronary cardiac interventions


The modified natural history of mitral regurgitation in patients undergoing transcatheter aortic valve implantation

Event: ESC Congress 2018

Topic: Pathophysiology and Mechanisms

Session: Best Posters in mitral regurgitation


Quantitative assessment of prosthetic valve regurgitation after TAVI by angiography and cardiac magnetic resonance imaging

Event: ESC Congress 2017

Topic: Aortic valve surgery

Session: Transcatheter aortic valve implantation


infective endocarditis after Melody valve implantation in the pulmonary position: a meta-analysis

Event: ESC Congress 2017

Topic: Grown-up congenital heart disease and surgery

Session: Long-term management and risk assessment after Tetralogy of Fallot repair


Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility

Event: ESC Congress 2016

Topic: Surgery and intervention in valve disease

Session: Valvular disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb